S189: early, deep, and durable responses, and low rates of crs with regn5458, a bcmaxcd3 bispecific antibody, in a phase 1/2 first-in-human study in patients with relapsed/refractory multiple myeloma

J. A. Zonder,J. Richter,N. Bumma, J. Brayer,J. E. Hoffman,W. I. Bensinger, K. L. Wu,L. Xu, D. Chokshi,A. Boyapati, D. Cronier,Y. Houvras, K. Rodriguez Lorenc, G. S. Kroog,M. V. Dhodapkar,S. Lentzsch,D. Cooper,S. Jagannath

HemaSphere(2022)

引用 3|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要